SCHAUMBURG, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MUSCULOSKELETAL TUMOR SOCIETY, founded in 1989, is a community nonprofit in the Medical Research sector that reported $1.0M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $1.1M exceeded revenue, resulting in a 12% operating deficit.
THE MISSION OF THE MUSCULOSKELETAL TUMOR SOCIETY IS TO ADVANCE THE SCIENCE OF ORTHOPAEDIC ONCOLOGY AND TO PROMOTE HIGH STANDARDS OF PATIENT CARE. IT DOES THIS THROUGH EXCELLENCE IN EDUCATION AND RESEARCH AND THROUGH ADVOCACY ON BEHALF OF PATIENTS AND ORTHOPAEDIC ONCOLOGISTS.
ANNUAL MEETING- A FORUM WHERE ORTHOPAEDIC SURGEONS WHO SPECIALIZE IN BONE TUMOR CANCERS CAN BE EDUCATED ON THE LATEST RESEARCH AND TREATMENTS.
SPECIALTY DAY - A ONE DAY PROGRAM FOR ORTHOPAEDIC SURGEONS TO SHAREORTHOPAEDIC ONCOLOGY INFORMATION DURING THE AMERICAN ACADEMY OFORTHOPAEDIC SURGEONS MEETINGS.
GRANTS AND AWARDS - THE BOARD ALLOCATES RESEARCH FUNDING TO ADVANCERESEARCH IN THE SPECIALTY OF ORTHOPAEDICS. THE BOARD IS RESPONSIBLEFOR ESTABLISHING CRITERIA FOR THE DISTRIBUTION OF FUNDS...
GRANTS AND AWARDS - THE BOARD ALLOCATES RESEARCH FUNDING TO ADVANCERESEARCH IN THE SPECIALTY OF ORTHOPAEDICS. THE BOARD IS RESPONSIBLEFOR ESTABLISHING CRITERIA FOR THE DISTRIBUTION OF FUNDS RAISED,CONDUCTING AN INDEPENDENT PEER REVIEW PROCESS, PREPARING PROMOTIONALINFORMATION AND DISTRIBUTING APPLICATIONS FOR RESEARCH GRANTS ANDAWARDS, AND MAKING DECISIONS REGARDING THE AWARDING OF FUNDS FOR RESEARCH CONSISTENT WITH PROGRAM GOALS AND OBJECTIVES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,011,009 | $930,533 | +0.1% |
| Expenses | $1,133,028 | $845,832 | +0.3% |
| Net Income | $-122,019 | $84,701 | -2.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHELLE GHERT | PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BENJAMIN MILLER | IMMEDIATE PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RAJIV RAJANI | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| FRANCIS YOUNGIN LEE | PRESIDENT-ELECT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ALAN BLANK | MEMBER-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW DICAPRIO | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GINGER HOLT | EDUCATION COMMITTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| BANG HOANG | RESEARCH COMMITTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| ODION BINITIE | MEMBERSHIP COMMITTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| NICHOLAS BERNTHAL | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LISA ERCOLANO | MEMBER-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| KERRI MINK | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$123,954 | $23,157 | $147,111 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,011,009 | $1,133,028 | $1,991,760 | $-122,019 |
| 2023 | $930,533 | $845,832 | $1,972,290 | $84,701 |
| 2022 | $964,650 | $732,326 | $1,841,901 | $232,324 |
| 2021 | $783,451 | $665,556 | $1,824,290 | $117,895 |
| 2020 | $375,978 | $343,180 | $1,609,103 | $32,798 |
| 2019 | $628,684 | $527,269 | $1,517,810 | $101,415 |
| 2018 | $705,553 | $515,497 | $1,297,435 | $190,056 |
Compare MUSCULOSKELETAL TUMOR SOCIETY with other nonprofits in Illinois and across the country.